drugset / Trial / NCT03043157

Rocuronium Effective Dose for Laparoscopic Cholecystectomy

NCT03043157

Phase 3 Completed 30 enrolled Brasilia University Hospital
NaSingle-groupOpen-labelSupportive care

Summary

This is an adaptative study where each participant's rocuronium dose will depend on the previous patient's response, being higher if it was not enough and lower if it was more than enough.

Timeline

Start
2017-02-15
Primary completion
2017-03-02
Completion
2017-03-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified 0.6 mg/kg Intravenous

Indications

No indication recorded.